Another limitation stems from the fact that the optimal blood glucose concentration for diagnosing GD remains controversial, and the outcome was measured using various indicators, such as fasting blood glucose (FBG), insulin concentration, insulin resistance and sensitivity indices, homeostasis model assessment of insulin resistance (HOMA-IR), QUICKI, and OGTT. The gene discussed is INS; the disease is Insulin resistance.